Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
DE Stocks

SY1.DE Symrise AG XETRA 27 Feb 2026: Q4 earnings due, model sees upside

February 27, 2026
6 min read
Share with:

The market closed with SY1.DE stock at EUR 77.58, up 2.16%, as investors position ahead of Symrise AG’s Q4 results due 4 March 2026. Trading volume reached 917,200 shares versus a 30-day average of 395,351, signaling above-normal attention. Key metrics show EPS 3.63 and PE 21.10, and the company reports two distinct revenue streams — Taste, Nutrition & Health, and Scent & Care. This earnings spotlight assesses how recent margin gains, cashflow trends, and debt metrics could shape the post-report move

SY1.DE stock: Earnings snapshot and market reaction

Symrise AG reports Q4 results on 2026-03-04; the market priced SY1.DE at EUR 77.58 at close on 27 Feb 2026. Today’s intraday range was EUR 76.08–78.06 with volume 917,200, above the average of 395,351, reflecting increased positioning into the print. Investors will watch organic growth, margin trajectory and any comment on raw-material pass-through and pricing.

Sponsored

The company’s last full-year figures show revenue EUR 5.00 billion (+5.67% year) and net income EUR 478.22 million (+40.46%), a backdrop that sets expectations for improvement in profitability this quarter source.

Q4 drivers: Sales, margins and segment outlook

Symrise’s two segments will determine the tone: Taste, Nutrition & Health and Scent & Care. Growth in natural ingredients and pet nutrition have supported top-line expansion. Management guidance and margin commentary on raw-material costs will be decisive for the stock reaction.

Analysts will probe operating profit margin and free cash flow. Last twelve months free cash flow per share stands at EUR 3.79, and operating cash flow per share is EUR 5.37, both metrics that matter for dividend coverage and buyback optionality.

Valuation and balance sheet metrics

On XETRA Symrise trades at PE 21.10 with EPS 3.63. Price-to-sales is 2.15, price-to-book is 2.88, and EV/EBITDA is 12.30, suggesting a mid-cap specialty chemicals valuation versus peers. Market cap is EUR 10.71 billion and shares outstanding are 139,772,054.

Balance-sheet flags: debt-to-equity is 0.65 and interest coverage is low at 0.32, indicating sensitivity to interest cost changes. Dividend per share is EUR 1.20, a yield near 1.57%. These ratios frame risk around leverage and margin resilience.

Technicals and trading setup for SY1.DE stock

Technically SY1.DE shows neutral-to-positive momentum. RSI is 58.84, MACD histogram is 0.11, and ADX is 24.29, indicating a trend that could strengthen if earnings beat. The price sits above the 50-day average (EUR 71.37) but below the 200-day average (EUR 80.29), so the 200-day is a resistance level to watch.

Short-term indicators point to moderate volatility: ATR EUR 1.98 and Bollinger upper band EUR 78.91. A clean beat could push the stock back toward the year high EUR 107.20; a miss could revisit the year low EUR 64.70.

Meyka AI rates SY1.DE with technical and fundamental grading

Meyka AI rates SY1.DE with a score of 74.42 out of 100 — Grade B+, Suggestion: BUY. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The company rating (26 Feb 2026) shows mixed metric scores: strong DCF, ROE and ROA signals, offset by weaker PE and debt efficiency scores.

This proprietary grade is informational and not a guarantee. Investors should weigh the grade against upcoming Q4 detail, interest coverage risk, and sector cycles. For context on market commentary see MarketBeat coverage of Symrise source.

Price scenarios and analyst-style targets

We outline three realistic scenarios tied to the earnings result: conservative target EUR 65.00 (implies -16.22% vs EUR 77.58), base target EUR 78.00 (+0.54%), and bullish target EUR 95.00 (+22.46%). Each scenario depends on organic growth, margin recovery and working-capital execution.

These targets are scenario-based, not firm analyst recommendations. Watch cash conversion cycle (currently long at 176 days) and inventory turn, which materially affect free cash flow and valuation in the near term.

Final Thoughts

Key takeaways for SY1.DE stock ahead of the Q4 print: current price is EUR 77.58, supported by above-average volume 917,200, and set against solid full-year 2024 trends — revenue EUR 5.00 billion and net income EUR 478.22 million. Valuation is mixed: PE 21.10 and EV/EBITDA 12.30 offer a reasonable multiple, while interest coverage 0.32 and a long cash-conversion cycle remain structural risks. Meyka AI’s forecast model projects a 12-month price of EUR 57.25, implying -26.21% from today’s close, while the one-month model sits at EUR 71.10 (-8.36%). Forecasts are model-based projections and not guarantees. Investors should watch organic growth, margin commentary and cash-flow guidance in the earnings release, and treat any significant guidance shift as the primary driver for next-week trading on XETRA in Germany. Meyka AI provides this as an AI-powered market analysis platform input; use these data points alongside your own research when forming positions.

FAQs

When does Symrise report earnings and why does it matter for SY1.DE stock?

Symrise reports Q4 results on 4 March 2026. The report matters for SY1.DE stock because it will update guidance, margins and cash flow, which can change valuation multiples and trigger immediate re-rating by investors.

What are the main valuation metrics for SY1.DE stock to watch?

Key metrics include PE 21.10, EV/EBITDA 12.30, price-to-sales 2.15 and dividend per share EUR 1.20. These show a mid-cap specialty chemical valuation with modest yield and room for margin improvement.

How does Meyka AI view SY1.DE stock and what is the forecast?

Meyka AI assigns SY1.DE a score of 74.42/100 (Grade B+, Suggestion: BUY). The model projects one-month EUR 71.10 and 12-month EUR 57.25, with caveats that model outputs are projections, not guarantees.

Which operational risks could hurt SY1.DE stock after earnings?

Operational risks include raw-material cost spikes, slower demand in Scent & Care, weaker interest coverage given low 0.32 ratio, and longer inventory cycles. Any negative guidance on these areas could pressure SY1.DE stock.

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
Meyka Newsletter
Get analyst ratings, AI forecasts, and market updates in your inbox every morning.
12% average open rate and growing
Trusted by 4,200+ active investors
Free forever. No spam. Unsubscribe anytime.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask our AI about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)